Evidence map›Paper›PMID 27806049›Full record

ArticlePLoS neglected tropical diseases2016

Containing Ebola at the Source with Ring Vaccination.

Stefano Merler, Marco Ajelli, Laura Fumanelli, Stefano Parlamento, Ana Pastore Y Piontti, Natalie E Dean, Giovanni Putoto, Dante Carraro, Ira M Longini, M Elizabeth Halloran and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Role of modelling in COVID-19 policy development.Paediatric respiratory reviews · 2020
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Stefano MerlerBruno Kessler Foundation, Trento, Italy.
Marco AjelliBruno Kessler Foundation, Trento, Italy.
Laura FumanelliBruno Kessler Foundation, Trento, Italy.
Stefano ParlamentoBruno Kessler Foundation, Trento, Italy.
Ana Pastore Y PionttiLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, Massachusetts, United States of America.
Natalie E DeanDepartment of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, United States of America.
Giovanni PutotoDoctors with Africa-CUAMM, Padua, Italy.
Dante CarraroDoctors with Africa-CUAMM, Padua, Italy.
Ira M LonginiDepartment of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, United States of America.
M Elizabeth HalloranVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Alessandro VespignaniLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, Massachusetts, United States of America.
Fondazione Bruno Kessler · ITDoctors with Africa Cuamm · ITUniversity of Florida · USFred Hutch Cancer Center · USInstitute for Scientific Interchange · ITNortheastern University · US

Funding

Understanding Transmission with Integrated Genetic and Epidemiologic InferenceU54GM111274 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BEDFORD, TREVOR BC · 2014 to 2018
$12.5M
Methods for Evaluating Vaccine EfficacyR37AI032042 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HALLORAN, M ELIZABETH · 2010 to 2019
$5.1M
NIAID NIH HHS R37 AI032042NIGMS NIH HHS U54 GM111274
6 · The paper itself

Abstract

Interim results from the Guinea Ebola ring vaccination trial suggest high efficacy of the rVSV-ZEBOV vaccine. These findings open the door to the use of ring vaccination strategies in which the contacts and contacts of contacts of each index case are promptly vaccinated to contain future Ebola virus disease outbreaks. To provide a numerical estimate of the effectiveness of ring vaccination strategies we introduce a spatially explicit agent-based model to simulate Ebola outbreaks in the Pujehun district, Sierra Leone, structurally similar to previous modelling approaches. We find that ring vaccination can successfully contain an outbreak for values of the effective reproduction number up to 1.6. Through an extensive sensitivity analysis of parameters characterising the readiness and capacity of the health care system, we identify interventions that, alongside ring vaccination, could increase the likelihood of containment. In particular, shortening the time from symptoms onset to hospitalisation to 2-3 days on average through improved contact tracing procedures, adding a 2km spatial component to the vaccination ring, and decreasing human mobility by quarantining affected areas might contribute increase our ability to contain outbreaks with effective reproduction number up to 2.6. These results have implications for future control of Ebola and other emerging infectious disease threats.

Indexed as

Ebola VaccinesEbolavirusGuineaHemorrhagic Fever, EbolaHumansModels, BiologicalSierra LeoneVaccinationEbola Vaccines

Identifiers

PMID27806049
PMCPMC5091901
OpenAlexW2547415311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.